Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy

被引：1
|
作者：
Aydiner, Adnan [1 ]
Sari, Murat [1 ]
机构：
[1] Istanbul Univ, Inst Oncol, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21212
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21212
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors
    Hyun Sun Woo
    Hee Kyung Ahn
    Ha Yeon Lee
    Inkeun Park
    Young Saing Kim
    Junshik Hong
    Sun Jin Sym
    Jinny Park
    Jae Hoon Lee
    Dong Bok Shin
    Eun Kyung Cho
    Investigational New Drugs, 2014, 32 : 1311 - 1315
  • [2] Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors
    Woo, Hyun Sun
    Ahn, Hee Kyung
    Lee, Ha Yeon
    Park, Inkeun
    Kim, Young Saing
    Hong, Junshik
    Sym, Sun Jin
    Park, Jinny
    Lee, Jae Hoon
    Shin, Dong Bok
    Cho, Eun Kyung
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (06) : 1311 - 1315
  • [3] Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) impact on immune microenvironment in non-small cell lung cancer (NSCLC).
    Tang, Jie
    Liu, XiaoLing
    Gong, Youling
    Zhu, Jiang
    Huang, Meijuan
    Ding, Zhenyu
    Yu, Min
    Tie, Yan
    Li, Qiu
    Wang, Yongsheng
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Clonal dominance of EGFR and efficacy of EGFR-tyrosine kinase inhibitors (EGFR-TKIs) in NSCLC.
    Ai, Xinghao
    Chen, Rongrong
    Cui, Jiuwei
    Zhang, Jiexia
    Lin, Wen
    Xie, Congying
    Hu, Xiaohua
    Zhang, Junping
    Jiao, Xiaodong
    Rao, Chuangzhou
    Yang, Weihua
    Chang, Lianpeng
    Xia, Xuefeng
    Yi, Xin
    Lu, Shun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CO-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND RESPONSE TO EGFR TYROSINE KINASE INHIBITORS (TKIS)
    Barnet, Megan B.
    O'Toole, Sandra
    Horvath, Lisa' G.
    Selinger, Christina
    Yu, Bing
    Trent, Ronald
    Ng, Chiu Chin
    Boyer, Michael J.
    Cooper, Wendy
    Kao, Steven
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 156 - 156
  • [6] Rebiopsy of patients with "acquired resistance" to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)
    Miller, Vincent A.
    Riely, Gregory J.
    Arcila, Maria E.
    Oxnard, Geoffrey
    Zakowski, Maureen F.
    Kris, Mark G.
    Pao, William
    Ladanyi, Marc
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S314 - S314
  • [7] Hepatotoxicity of epidermal growth factor receptor - tyrosine kinase inhibitors (EGFR-TKIs)
    Zhu, Lulin
    Yang, Xinxin
    Wu, Shanshan
    Dong, Rong
    Yan, Youyou
    Lin, Nengming
    Zhang, Bo
    Tan, Biqin
    DRUG METABOLISM REVIEWS, 2024,
  • [8] Making progress in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer by surpassing resistance: third-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs)
    Mountzios, Giannis
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
  • [9] Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)
    Maria Martinez-Navarro, Elena
    Rebollo, Joseba
    Gonzalez-Manzano, Ramon
    Sureda, Manuel
    Evgenyeva, Elena
    Valenzuela, Belen
    Jose Fernandez, Francisco
    Forteza, Jeronimo
    Brugarolas, Antonio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (11): : 812 - 818
  • [10] Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)
    Elena María Martínez-Navarro
    Joseba Rebollo
    Ramón González-Manzano
    Manuel Sureda
    Elena Evgenyeva
    Belén Valenzuela
    Francisco José Fernández
    Jerónimo Forteza
    Antonio Brugarolas
    Clinical and Translational Oncology, 2011, 13 : 812 - 818
12345